Prostate post-implant dosimetry: Interobserver variability in seed localisation, contouring and fusion

Radiotherapy and Oncology

Volumn 104, Issue 2, 2012, Pages 192-198

  De Brabandere, Marisol ^a   Hoskin, Peter ^b   Haustermans, Karin ^a   Van Den Heuvel, Frank ^a   Siebert, Frank André ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MOUNT VERNON CANCER CENTRE   (United Kingdom)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Brachytherapy; Post planning; Prostate

Indexed keywords

IODINE 125; RADIOACTIVE SEED;

ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DOSIMETRY; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGE RECONSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; POST IMPLANT PROSTATE CONTOURING; PRIORITY JOURNAL; PROSTATE; PROSTATE RADIOACTIVE SEED IMPLANT RECONSTRUCTION; PROSTATE VOLUME; RADIATION DOSE; TESTIS SIZE;

BRACHYTHERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SAFETY MANAGEMENT; SAMPLING STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865718683     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.06.014     Document Type: Article

References (27)

1. D. Ash, A. Flynn, J. Battermann, T. de Reijke, P. Lavagnini, and L. Blank ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
2. S. Nag, D. Beyer, J. Friedland, P. Grimm, and R. Nath American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
3. C. Salembier, P. Lavagnini, and P. Nickers Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy Radiother Oncol 83 2007 3 10
4. J. Crook, M. McLean, I. Yeung, T. Williams, and G. Lockwood MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy Brachytherapy 3 2004 55 60
5. P. McLaughlin, V. Narayana, and M. Kessler The use of mutual information in registration of CT and MRI datasets post permanent implant Brachytherapy 3 2004 61 70
6. A. Polo, F. Cattani, and A. Vavassori MR and CT image fusion for postimplant analysis in permanent prostate seed implants Int J Radiat Oncol Biol Phys 60 2004 1572 1579
7. D.F. Dubois, B.R. Prestidge, L.A. Hotchkiss, J.J. Prete, and W.S. Bice Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy Radiology 207 1998 785 789
8. E. Berthelet, M.C. Liu, A. Agranovich, K. Patterson, and T. Currie Computed tomography determination of prostate volume and maximum dimensions: a study of interobserver variability Radiother Oncol 63 2002 37 40
9. B. Al-Qaisieh, D. Ash, D.M. Bottomley, and B.M. Carey Impact of prostate volume evaluation by different observers on CT-based postimplant dosimetry Radiother Oncol 62 2002 267 273
10. M. De Brabandere, C. Kirisits, R. Peeters, K. Haustermans, and F. Van den Heuvel Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom Radiother Oncol 79 2006 190 197
11. F. Siebert, M. De Brabandere, C. Kirisits, G. Kovacs, and J. Venselaar Phantom investigations on CT seed imaging for interstitial brachytherapy Radiother Oncol 85 2007 316 323
12. P. Mangili, L. Stea, and F. Cattani Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes Radiother Oncol 71 2004 13 21
13. M.J. Rivard, B.M. Coursey, and L.A. DeWerd Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations Med Phys 31 2004 633
14. C. Rasch, I. Barillot, P. Remeijer, A. Touw, M. van Herk, and J.V. Lebesque Definition of the prostate in CT and MRI: a multi-observer study Int J Radiat Oncol Biol Phys 43 1999 57 66
15. M. Debois, R. Oyen, and F. Maes The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer Int J Radiat Oncol Biol Phys 45 1999 857 865
16. W.L. Smith, C. Lewis, and G. Bauman Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT and MR Int J Radiat Oncol Biol Phys 67 2007 1238 1247
17. J.J. Prete, B.R. Prestidge, W.S. Bice, D.F. Dubois, and L.A. Hotchkiss Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy Radiat Oncol Invest 6 1998 90 96
18. E.L. Khoo, K. Schick, A.W. Plank, M. Poulsen, W.W. Wong, and M. Middleton Prostate contouring variation: can it be fixed? Int J Radiat Oncol Biol Phys 82 2012 1923 1929
19. H. Schiefer, F. von Toggenburg, and W.W. Seelentag Topological methods for the comparison of structures using LDR-brachytherapy of the prostate as an example Phys Med Biol 54 2009 4959 4970
20. R. Stock, N. Stone, A. Tabert, C. Iannuzzi, and J.K. DeWyngaert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108
21. L. Potters, Y. Cao, E. Calugaru, T. Torre, P. Fearn, and X. Wang A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 50 2001 605 614
22. E. Gastaldi, L. Chiono, and F. Gallo Dosimetry doesn't seem to predict the control of organ-confined prostate cancer after I-125 brachytherapy Arch Ital Urol Androl 81 2009 215 217
23. W.M. Butler, R.R. Stewart, and G.S. Merrick Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parameters Brachytherapy 10 2011 16 28
24. P. Orio, K. Wallner, and G. Merrick Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation Int J Radiat Oncol Biol Phys 67 2007 342 346
25. D. Ash, B. Al-Qaisieh, D. Bottomley, B. Carey, and J. Joseph The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer Radiother Oncol 79 2006 185 189
26. N.P. Munro, B. Al-Qaisieh, P. Bownes, J. Smith, B. Carey, and D. Bottomley Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years Radiother Oncol 96 2010 34 37
27. W.R. Lee Permanent prostate brachytherapy: the significance of postimplant dosimetry Rev Urol 6 2004 49 56